Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A

Subhashis Sarkar, Michel van Gelder, Willy Noort, Yunping Xu, Kasper M. A. Rouschop, Richard Groen, Harry C. Schouten, Marcel G. J. Tilanus, Wilfred T. V. Germeraad, Anton C. M. Martens, Gerard M. J. Bos, Lotte Wieten*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)951-963
JournalCancer Immunology Immunotherapy
Volume64
Issue number8
DOIs
Publication statusPublished - Aug 2015

Keywords

  • NK cell
  • Multiple myeloma
  • HLA
  • Immunotherapy
  • KIR
  • NKG2A

Cite this